IGF-1 mediates many of growth hormones anabolic effects including muscle growth, bone growth and density, tissue repair and regrowth, and collagen synthesis
Interestingly, a human study has shown increases in plasma acylcarnitines with healthy aging ( APOE genotypes (Shang et al., 2020)
Common outcomes include: Gradual and sustainable weight loss Noticeable appetite reduction Improved portion control Fewer cravings Better metabolic stability Oral GLP-1 therapy is not one-size-fits-all
And he thinks that's a problem
The common side effects of GLP-1 analogues include constipation and gastrointestinal discomfort, which are usually temporary and manageable
What is not yet visible: No skin tone changes, no measurable liver enzyme shifts, and no immune function differences at this stage